Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1

5(62.5%)

N/A

2(25.0%)

Phase 3

1(12.5%)

8Total

Phase 1(5)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06408103Not ApplicableRecruiting

Efficacy of a Multicomponent Intervention on Cognitive Function for the Caregiver-patient Dyad

Role: collaborator

NCT07149753Phase 1Not Yet Recruiting

Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis

Role: collaborator

NCT06304025Phase 1Not Yet Recruiting

Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line Treatment

Role: lead

NCT05631444Phase 1Completed

Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia

Role: lead

NCT04863183Phase 1Unknown

Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis

Role: lead

NCT03779737Not ApplicableCompleted

Resistance and Aerobic Training, Relationship With Birth Weight in Colombian Children

Role: lead

NCT02943486Phase 1Unknown

Mesenchymal Stromal Cell Derivatives in the Treatment of Chronic Diabetic Foot Ulcers Type 1 and 2

Role: collaborator

NCT00841750Phase 3Unknown

Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection

Role: lead

All 8 trials loaded